Medline ® Abstract for Reference 124
of 'Noninvasive assessment of hepatic fibrosis: Overview of serologic and radiographic tests'
124
TI
Transforming growth factor beta 1: in situ expression in the liver of patients with chronic hepatitis C treated with alpha interferon.
AU
Bedossa P, Poynard T, Mathurin P, Lemaigre G, Chaput JC
SO
Gut. 1993;34(2 Suppl):S146.
In a semiquantitative assessment of the expression of transforming growth factor (TGF) beta 1 in liver biopsy specimens from patients with chronic hepatitis C, treatment with interferon alfa-2b (3 million units (MU) three times weekly) decreased the expression of TGF beta 1 in six of seven patients. The reduction in TGF beta 1 correlated significantly with the scores for inflammation (p<0.05) and necrosis (p<0.05), but not with the alanine aminotransferase activities (p = 0.36) or the score for fibrosis (p = 0.86).
AD
Laboratoire d'Anatomie Pathologique, Hôpital Antoine Beclere, Clamart, Paris, France.
PMID